BioPharm International, April 2012 Issue (PDF)
Optimizing Filtration Strategies
A Strong Start to 2012
Better news about the global economy buoys life-sciences funding.
Pointed Debate
Industry experts discuss the benefits and challenges of self-administration of injectable therapies.
Optimizing Adjuvant Filtration
A technical rountable featuring Sartorius Stedim Biotech, Pall Life Sciences, 3M Purification, Asahi Kasei Bioprocess, and Bio-Rad Laboratories.
Preparing for an FDA Inspection in a Global Pharmaceutical Environment
FDA has created a dedicated cadre of foreign drug investigators and established permanent offices worldwide.
The Growing Orphan-Drug Paradigm
Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.
Manufacturers Wrestle with Drug Abuse and Critical Shortages
Soaring opioid use creates challenges for new drug development and supply-chain control.
Small Changes, System-Wide Impact
A closer look at elastomer changeout times provides one example of using industry knowledge to improve operations and cost.
Knowledge Management Implementation
The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.
Ways to Recover Lost Margins
Recovery audits and other best practices in procurement can improve the bottom line.
Single-Use Redundant Filtration
The authors describe a new assembly for bulk and final drug product filling operations.
Growing Your Biopharmaceutical Product Pipeline
BioPharm talks with Tarja Mottram, CEO of Action for Results, about key business considerations when starting out.
A 25-Year Retrospective on GMP Training
This month, we rewind to an article titled "Good Manufacturing Practices Training."
A Look at INTERPHEX 2012
Collaboration can begin with a conversation.
PDA Tackles Changing Industry Times
The confluence of science, technology, and regulation will provide our industry with the guidance to move forward.
